한국융합학회논문지 (Journal of the Korea Convergence Society)

  • 제9권10호
  • /
  • Pages.93-101
  • /
  • 2018
  • /
  • 2233-4890(pISSN)
  • /
  • 2713-6353(eISSN)
한국융합학회 (Korea Convergence Society)
권호 표지
DOI QR코드

DOI QR Code

사람 구강암세포에서 쿼세틴에 의한 항암 및 항전이 효과에 관한 융합연구

Convergence study on anticancer and antimetastasis effect by quercetin in human oral cancer cells

  • 강해미 (부산대학교 치의학전문대학원 구강해부학교실) ;
  • 길종진 (부산대학교 치의학전문대학원 구강해부학교실) ;
  • 박봉수 (부산대학교 치의학전문대학원 구강해부학교실) ;
  • 강현경 (신라대학교 보건복지대학 치위생학과) ;
  • 김인령 (부산대학교 치의학전문대학원 구강해부학교실)
  • Kang, Hae-Mi (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kil, Jong-Jin (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Park, Bong-Soo (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kang, Hyun-Kyung (Department of Dental Hygiene, Silla university) ;
  • Kim, In-Ryoung (Department of Oral Anatomy, School of Dentistry, Pusan National University)
  • 투고 : 2018.07.20
  • 심사 : 2018.10.20
  • 발행 : 2018.10.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

본 연구는 천연 플라보노이드계 물질인 쿼세틴을 사람 구강암세포주인 HSC-2 세포에 처리한 후 나타나는 항암 및 항전이 효과를 보기 위함이다. 연구 결과를 통하여 쿼세틴은 HSC-2 세포의 세포생존율 과 세포증식율이 감소하였으며, 이 세포 사멸의 경로는 세포 자살 프로그램인 세포자멸사의 경로를 통하여 일어나는 것임을 확인하였다. 또한 세포사멸에 큰 영향을 주지 않았던 농도인 쿼세틴 $100{\mu}M$ 처리군부터 HSC-2 세포의 이동력 과 침습력을 억제하는 효과가 있음을 확인하였다. 따라서 본 연구자는 종합적인 실험 결과를 통하여 구강암 세포에 있어서 $200{\mu}M$이상의 쿼세틴 처리는 세포자살 프로그램을 가동하여 세포사멸을 유도하고, $100{\mu}M$ 이상의 쿼세틴 처리는 세포의 이동과 침습을 억제하여 항암, 항전이 활성을 일으키는 것을 밝혔다. 그러므로 쿼세틴은 구강암에 있어 전이를 억제하고 암을 치료하기 위한 항암제로서 충분한 가치가 있음을 시사한다.

This study was conducted to investigate the anticancer and antitumor effects of quercetin, which is a natural flavonoid substance in human oral cancer cell line HSC-2 cells. The results of this study showed that quercetin reduses the cell viability and the cell proliferation rate, and it led to the evidences of cell death through apoptosis pathway. Also, lower concetration quercetin over $100{\mu}M$ were inhibited the cell migration and invasion. In the present study, we conclude that quercetin treatment of more than $200{\mu}M$ induces apoptosis by activating programed cell death and quercetin treatment of $100{\mu}M$ or more inhibits the cell migration and invasion rate in oral cancer cells. Therefore, this study suggests that quercetin is of sufficient value as an anticancer drug to inhibit metastasis and to treat cancer.

키워드

참고문헌

  1. S. Franceschi, E. Bidoli, R. Herrero & N. Munoz (2000). Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncology, 36(1), 106-115. DOI : 10.1016/S1368-8375(99)00070-6
  2. J. H. Han, E. K. Kim, S. H Lim & C. H. Kim (2012). Literature Review on the Incidence and Risk Factor of Oral Cancer. J Dent Hyg Sci, 12(5), 451-458.
  3. A. Jemal, R. Siegel, J. Xu & E. Ward (2010). Cancer statistics, 2010. CA Cancer J Clin, 60(5), 277-300. DOI : 10.3322/caac.20073
  4. R. C. Budd (1997). An overview of apoptosis. Coron Artery Dis, 8(10), 593-597. https://doi.org/10.1097/00019501-199710000-00002
  5. M. Okura, T. Aikawa, N. Y. Sawai, S. Iida & M. Kogo (2009). Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncology, 45(10), 908-911. DOI : 10.1016/j.oraloncology.2009.03.013
  6. L. J. Talbot, S. D. Bhattacharya & P. C. Kuo (2012). Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int J Biochem Mol Biol, 3(2), 117-136.
  7. Y. U. Kim, K. J. Kim, E. P. Heo (2015). The Epithelial-Mesenchymal Transition and E-cadherin and Vimentin Expression in Basal Cell Carcinoma and Squamous Cell Carcinoma. Ann Dermatol, 53(2), 96-105.
  8. J. J. Monsuez, J. C. Charniot, N. Vignat & J. Y. Artigou (2010). Cardiac side-effects of cancer chemotherapy. Int J Cardiol, 144(1), 3-15. DOI : 10.1016/j.ijcard.2010.03.003
  9. J. H Nho , M. O. Sim, H. K. Jung, M. J. Lee, J. H. Jang, D. E. Jung, S. T. K. Sung, B. K. An & H. W. Cho (2018). Anti-colorectal Cancer and Anti-oxidant Activities of Rubiae radix Ethanol Extract in vitro. Korean J. Plant Res, 31(2), 102-108 https://doi.org/10.7732/KJPR.2018.31.2.102
  10. J. H. Kim & E. J. Kim (2016). Effect of Anti-oxidant, Anti-inflammatory and Anti-invasive of PMA-induced Matrix Metalloproteinase (MMP-2) and MMP-9 Activities of Water Extract and Solvent Fractions of Saururus Chinensis. Journal of Life Science, 26(5), 584-591. DOI : 10.5352/JLS2016.26.5.584
  11. G. Di Carlo, N. Mascolo, A. A. Izzo & F. Capasso (1999). Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci, 65(4), 337-353 DOI : 10.1016/S0024-3205(99)00120-4
  12. H. M. Kubisch, J. Wang, T. M. Bray & J. P. Phillips (1997). Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes, 46(10), 1563-1566. DOI : 10.2337/diacare.46.10.1563
  13. B. S. Park, J. J Kil, H. M. Kang, S. B. Yu, D. B. Park, J. A. Park & I. R. Kim (2018). Luteolin Induces Apoptosis via Mitochondrial Pathway and Inhibits Invasion and Migration of Oral Squamous Cell Carcinoma by Suppressing Epithelial-Mesenchymal Transition Induced Transcription Factors. International Journal of Oral Biology, 43(2), 69-76. DOI : 10.11620/IJOB.2018.43.2.069
  14. J. A. Choi, J. Y. Kim, J. Y. Lee, C. M. Kang, H. J. Kwon, Y. D. Yoo, T. W. Kim, Y. S. Lee & S. J. Lee (2001). Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol, 19(4), 837-844 DOI : 10.3892/ijo.19.4.837
  15. H. Yang, T. C. Hsia, H. M. Kuo, P. D. Chao, C. C. Chou, Y. H. Wei & J. G. Chung (2006). Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos, 34(2), 296-304. DOI : 10.1124/dmd.105.005280
  16. M. Yoshizumi, K. Tsuchiya, K. Kirima, M. Kyaw, Y. Suzaki & T. Tamaki (2001). Quercetin inhibits Shc-and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol, 60(4), 656-665.
  17. J. L. Fernandez-Luna (2007). Apoptosis regulators as targets for cancer therapy. Clinical & Translational Oncology, 9(9), 555-562. DOI : 10.1007/s12094-007-0103-7
  18. S. Elmore (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol, 35(4), 495-516 DOI : 10.1080/01926230701320337
  19. L. Ouyang, Z. Shi, S. Zhao, F. T. Wang, T. T. Zhou, B. Liu & J. K. Bao (2012). Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif, 45(6), 487-498. DOI : 10.1111/j.1365-2184.2012.00845.x
  20. J. K. Brunelle & A. Letai (2009). Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci, 122(Pt 4), 437-441. DOI : 10.1242/jcs.031682
  21. C. Garrido, L. Galluzzi, M. Brunet, P. E. Puig, C. Didelot & G. Kroemer (2006). Mechanisms of cytochrome c release from mitochondria. Cell Death Differ, 13(9), 1423-1433. DOI : 10.1038/sj.cdd.4401950
  22. A. Voulgari & A. Pintzas (2009). Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta, 1796(2), 75-90. DOI : 10.1016/j.bbcan.2009.03.002
  23. R. Kalluri & R. A. Weinberg (2009). The basics of epithelial-mesenchymal transition. J Clin Invest, 119(6), 1420-1428. DOI : 10.1172/JCI39104
  24. X. Li, X. Zhao, W. Song, Z. Tian, L. Yang, Q. Niu, Q. Zhang, M. Xie, B. Zhou & Y. Xu (2018). Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to- Mesenchymal Transition in Human Pancreatic Cancer Cell. Yonsei medical journal, 59(1), 20-27. DOI : 10.3349/ymj.2018.59.1.20